Vice President
Sarepta Therapeutics, Inc.
Lilly East is the Vice President and Head of Quantitative & Clinical Pharmacology at Sarepta Therapeutics. Lilly is an experienced leader in drug development with expertise in translational and clinical pharmacology, pharmacometrics, data analytics and biomarker development. Over the past 15 years, Lilly has gained specializations in small chemical entities, oligonucleotides, gene therapy and biologics, with notable achievements in global approvals and registration of high-profile approvals in CNS (Depression, Alzheimer’s Disease, Multiple Sclerosis), neuromuscular disorders (SMA, DMD, LGMD), immuno-oncology, and infectious diseases (HIV). In addition, Lilly has a wide spectrum of drug development and regulatory engagement experience across Research, all phases of clinical development, product registration and life cycle management. Lilly obtained her Ph.D. in Clin Pharmacology and Pharmacokinetics from University of Washington, her B.S in dual majors Biochemistry and Molecular Cell Biology from University of California, Berkeley.